| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 107 | 387 | 170 | 4.506 | 7.794 | 3.358 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 107 | 387 | 170 | 4.506 | 7.947 | 3.358 |
| Total Expenses - EUR | 143 | 319 | 211 | 4.073 | 537 | 987 | 1.876 | 27.688 | 14.573 | 4.947 |
| Gross Profit/Loss - EUR | -143 | -319 | -211 | -4.073 | -429 | -601 | -1.706 | -23.182 | -6.626 | -1.589 |
| Net Profit/Loss - EUR | -143 | -319 | -211 | -4.073 | -433 | -612 | -1.706 | -23.257 | -6.626 | -1.589 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Vimimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 24.353 | 21.515 | 23.712 | 20.763 | 20.361 | 19.975 | 19.532 | -8 | -8 | 0 |
| Current Assets | 7.847 | 10.711 | 7.964 | 5.702 | 6.182 | 6.368 | 6.521 | 5.871 | 6.813 | 6.521 |
| Inventories | 240 | 527 | 518 | 0 | 464 | 697 | 765 | 0 | 0 | 0 |
| Receivables | 7.586 | 10.206 | 7.489 | 5.746 | 5.711 | 5.672 | 5.639 | 5.576 | 4.972 | 5.106 |
| Cash | 20 | -22 | -43 | -44 | 7 | -1 | 117 | 295 | 1.841 | 1.415 |
| Shareholders Funds | -14.165 | -14.340 | -14.308 | -18.118 | -18.200 | -18.467 | -19.763 | -43.081 | -49.576 | -50.888 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 46.365 | 46.566 | 45.984 | 44.583 | 44.742 | 44.810 | 45.815 | 48.944 | 56.381 | 57.409 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Vimimed S.r.l.